Introduction
A pulse is a rhythmic wave produced by ventricular contraction during systole. A double pulse noticed during systole in the peripheral pulse is called pulsus bisferiens. This is derived from the Latin word, which means strike twice (bis=twice, ferio=strike). It is also called a biphasic wave. Pulsus bisferiens was described by ancient physicians, including Galen in his work De Pulsibus during the second century AD..[1]
Pulsus bisferiens is associated with severe aortic disease accompanied by aortic regurgitation and hypertrophic obstructive cardiomyopathy (HOCM).[2] Providers often confuse this with the dicrotic pulse. The main distinguishing feature of pulsus bisferiens is that two peaks are seen in systole. In contrast, a dicrotic pulse is characterized by one peak in systole and the other in diastole. Dicrotic pulse is seen in the low cardiac output state, sepsis, and cardiac tamponade.
Definition
Pulsus bisferiens is a single central pulse wave with two peaks separated by a distinct mid-systolic dip. An early component percussion wave results from rapid left ventricular ejection. The late component tidal wave represents a reflected wave from the periphery due to an artery's recoil effect.
History
Medical literature has made many revelations about the pulse way back in the first and second centuries AD.[1]
- Clinical observations of the double pulse were first made by Galen (circa 129–216 AD) in his work De Pulsibus.[1]
- Mahomed (1872) was the first to describe the terms percussion wave and tidal wave
- Broadbent, in 1900 noticed pulsus bisferiens in context to aortic valve disease[3]
- Bramwell (1937) put forward the theory of the genesis of the abnormal pulse
- Fleming described the mechanism of pulsus bisferiens in 1957[1]
Etiology
Register For Free And Read The Full Article
- Search engine and full access to all medical articles
- 10 free questions in your specialty
- Free CME/CE Activities
- Free daily question in your email
- Save favorite articles to your dashboard
- Emails offering discounts
Learn more about a Subscription to StatPearls Point-of-Care
Etiology
The most common causes of pulsus bisferiens are:
- Mixed aortic valve diseases, such as infective endocarditis, rheumatic heart disease, Marfan syndrome, and bicuspid aortic valve[4][5]
- Hypertrophic cardiomyopathy with obstruction (HOCM)
Other causes are:
Epidemiology
Pulsus bisferiens is commonly seen in mixed aortic disease with severe aortic regurgitation and hypertrophic cardiomyopathy.
- The incidence of aortic regurgitation is high in the fourth to sixth decade of life, increases with age, and is more common in the elderly. It is more common in men (13%) than women (8.5%). The Framingham study reported the prevalence of aortic regurgitation at 4.9% and severe aortic regurgitation at 0.5% in the US population.[7]
- Hypertrophic obstructive cardiomyopathy (HOCM) is the most common genetically inherited heart disease. Prevalence rates of HOCM vary across the globe. The prevalence in the US is 1 in 500 (0.2%), and in Germany is 1 in 1,372 (0.07%).[8][9] Males are affected more compared to females.
- Rheumatic heart disease and bacterial endocarditis are more common in developing countries (Asia, Africa). The incidence of aortic disease is 10 cases per 100,000 to as high as 374 cases per 100,000 in the Pacific and Australia.
Pathophysiology
The mechanism of pulsus bisferiens is not entirely understood. A normal central pulse has two waves; a percussion wave (larger) and a tidal wave (smaller). It is not easy to distinguish them clinically, as it happens in quick succession. But in some pathological conditions, these are exaggerated by a wider mid-systolic gap leading to two distinct waves.
It is postulated that a large, rapidly ejected left ventricular stroke volume is associated with left ventricular changes in pressure over time, resulting in percussion waves. The second wave (tidal wave) is caused by the backpressure exerted by the recoil of arterial musculature. Katz et al. (1927) also described the theory of a venturi effect caused by the high flow of blood in the ascending aorta. This theory has not received much attention from researchers.[2]
- Mixed Aortic Valve Disease: In patients with aortic regurgitation with aortic stenosis, a regurgitant stroke volume results in smaller peak waves (percussion wave), and aortic stenosis results in mid-systolic dip followed by a taller second wave (tidal wave) in systole.
- Hypertrophic Obstructive Cardiomyopathy (HOCM): Rapid ventricular ejection results in a larger percussion wave, whereas outflow obstruction leads to a mid-systolic gap followed by a second smaller tidal wave.[10]
- Patent Ductus Arteriosus (PDA): Newborns presenting with severe PDA (large left-to-right shunt), a large stroke volume results in a taller first wave (percussion wave), and large runoff resulting in a second smaller wave (tidal wave).
History and Physical
Age gives crucial clues to the diagnosis of the disease. The pediatric age group with a palpable pulse with two strokes should indicate PDA with a left to right shunt. The younger patient usually points towards a diagnosis of hypertrophic cardiomyopathy with an obstruction or bicuspid valve disease, whereas mixed aortic valve disease is more common in the elderly population. Pulsus bisferiens can be more pronounced by the Valsalva maneuver.
History
Common clinical presentations are syncope, dyspnea, chest pain, and palpitations. Long-standing problems can remain asymptomatic and present with signs of acute pulmonary edema and heart failure. HOCM can present with sudden cardiac death and life-threatening arrhythmias, especially in younger athletes.[8]
Physical Examination
On palpation of a peripheral pulse (radial artery), two upstrokes distinguished by a mid-systolic gap in the systole are characteristic of pulsus bisferiens.
- Wider pulse pressure is seen in aortic regurgitation.[11]
- Jugular venous pressure (JVP) examination may reveal a classical 'a' wave in HOCM.
- The apex beat is displaced in severe aortic regurgitation, whereas; in HOCM double beats can be felt at the apex.
- Auscultation: On careful cardiac evaluation, various murmurs can be heard during auscultation. The following murmurs can be observed along with pulsus bisferiens, which may clinch the clinical diagnosis. Ejection systolic murmur in the aortic area (aortic stenosis), early diastolic murmur on the left sternum (aortic regurgitation), mid-diastolic or early diastolic low-pitch rumble murmur at the apex (severe aortic regurgitation) which is also called as Austin Flint murmur, ejection systolic murmur along the left parasternal area (HOCM).[12]
Aortic regurgitation can also present with other clinical signs such as blanching and flushing of the forehead and face (lighthouse sign), bobbing of the head synchronous with the arterial pulse (de Musset sign), repeated flushing and blanching of the capillaries in the nail beds (Quincke sign), alternating systolic miosis and diastolic mydriasis in both pupils (Landolfi sign), pulsations of the retinal arteries on the fundoscopic examination (Becker sign), pulsations of the uvula (Muller sign), systolic pulsations of the liver (Rosenbach sign) and spleen (Gerhard sign), a pistol shot sound both during systole and during diastole on auscultation (Traube sign), diastolic-systolic murmur over the femoral arteries (Duroziez murmur).[13]
Evaluation
Serum Biomarkers: High sensitivity troponin T (Tn-T) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels are elevated in bicuspid aortic valve disease.[14]
Chest X-Ray: Chest X-ray can reveal LVH, left atrial enlargement, and heart failure (pulmonary edema).
ECG: Conduction abnormalities, atrial fibrillation (AF,) left ventricular hypertrophy, and left atrial hypertrophy are seen in both aortic valvular disease and HOCM.
2D-Echo: Echocardiography is the main diagnostic tool for diagnosing mixed aortic valve disease and HOCM. Assessment of valve morphology, determination of the aortic regurgitation jet, aortic regurgitation quantification, and measurement of the aortic root and ascending aorta can be done with 2D echocardiography. It helps in left ventricular assessment and measurement of its dimensions in valvular disease and hypertrophic cardiomyopathy. It also can be used to assess the morphology of the aorta and determine the feasibility of aortic surgery or valve repair.[12]
MRI: Cardiac magnetic resonance imaging is increasingly used to assess regurgitant lesion severity and ventricular function. Advances in noninvasive imaging help in objective measurements of valve disease severity, hemodynamic fluctuation, and structural complications. MRI is also used increasingly in accurately quantifying left ventricular (LV) remodeling. Cardiac MRI is the gold standard test in assessing patients with HOCM.[8][15]
CT: Cardiac and vascular CT has become an indispensable tool for the appropriate planning of transcatheter interventions. Useful in acquiring intracardiac and vascular access route dimensions with accuracy.[16]
Nuclear Imaging and Fluoroscopy: The extent of local infectious activity, metabolic activity, and the extent of calcium deposits can be evaluated with nuclear imaging and fluoroscopy.
Treatment / Management
Management of pulsus bisferiens is based on its etiology. Therefore, early diagnosis and referral to cardiologists are crucial to successful management, reducing mortality and morbidity. Mixed aortic valve disease and hypertrophic cardiomyopathy with obstruction are the most common causes of pulsus bisferiens.
Medical Management
- Mixed Aortic Valve Disease: Vasodilators may help symptomatic patients by reducing preload and increasing cardiac output. Rate control and blood pressure control with angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) might help. Beta-blockers may be less beneficial in treating patients with aortic regurgitation.[8]
- Hypertrophic Obstructive Cardiomyopathy (HOCM): β-blockers are the first line of medical management in HOCM. Calcium channel blockers verapamil and diltiazem are beneficial too and are used as second-line in the treatment.[17] ACE inhibitors and ARBs, because of their vasodilating properties, are better avoided. The use of vasodilators is contraindicated.
- Patent Ductus Arteriosus (PDA): Early use of indomethacin, ibuprofen, or acetaminophen to close a PDA soon after birth prevents further complications.[18] Diuretics can be used in treating acute pulmonary edema.
Surgical Management
- Mixed Aortic Valve Disease: Advances in surgical techniques, specifically those associated with valve repair; improved operative results; and enhanced perioperative management strategies, have contributed substantially to better patient outcomes. Valve-sparing surgical repair is becoming popular as a feasible alternative to routine surgeries. Transcatheter aortic valve replacement (TAVR) has revolutionized patients' treatment with symptomatic, severe aortic stenosis (AS) and now provides the least invasive treatment option for many patients.
- Hypertrophic Obstructive Cardiomyopathy (HOCM): Dual chamber pacemaker for severe HOCM and implantable cardioverter-defibrillator insertion may be indicated in the refractory ventricular arrhythmias. The surgical treatment for HOCM is myomectomy, which improves the outcome. Septal alcohol ablation may be effective in 90% of cases of severe HOCM.[19]
- Patent Ductus Arteriosus (PDA): Surgical ligation is indicated in a neonate with significant clinical PDA, but its role is controversial.[20]
Differential Diagnosis
An important differential diagnosis for a bisferiens pulse is a dicrotic pulse. It is always difficult to distinguish between these two clinically. In the dicrotic pulse, two peaks are palpable; one in systole and the other in diastole. Whereas in pulsus bisferiens, both peaks are seen in systole.[21] Dicrotic pulse is seen in cardiac failure and sepsis. Also, it is occasionally seen in normal individuals after exercise.
Prognosis
Mixed Aortic Valve Disease: The prognosis is generally good in patients with isolated severe aortic regurgitation (AR) who are asymptomatic and have a preserved LV function. Patients with moderate to severe AR have poor outcomes. Surgical intervention and aortic valve replacement (AVR) can improve the survival rate in symptomatic patients with LV dysfunction.
Hypertrophic Obstructive Cardiomyopathy (HOCM): The mortality rate is very low for patients with HOCM.[22] Generally, the long-term outcome is good. A small percentage of the population has a risk of sudden cardiac death.
Patent Ductus Arteriosus (PDA): PDA severity scores have been developed, which can be used to predict serious outcomes. Ductus closes spontaneously in most healthy newborns; only 3% of infants weighing more than 1,000 gms may require a PDA intervention.
Complications
Complications in patients who have pulsus bisferiens include:
- Heart failure
- Stroke
- Arrhythmias
- Infective endocarditis
- Sudden cardiac death
Deterrence and Patient Education
- The number of patients with significant severe mixed aortic disease who could benefit from appropriate intervention increases with age.
- Implementing optimal treatment strategies for patients with severe aortic disease, HOCM, or PDA will improve overall outcomes.
- Screening echocardiogram helps in early diagnosis and assessment of the severity of the disease.
- Screening is recommended for all first-degree relatives diagnosed with HOCM as it is an inherited disease.[23]
Pearls and Other Issues
- Pulsus bisferiens indicates severe cardiac disease and must be differentiated from a dicrotic pulse.
- It is commonly seen in mixed aortic disease and hypertrophic obstructive cardiomyopathy.
- Best felt in the peripheral arteries like radial, brachial, and femoral arteries.
- Echocardiography is the first-line diagnostic modality used to assess valve severity and its impact on the left ventricle function.
- Genetic screening would help prevent, diagnose, and manage patients with HOCM.
Enhancing Healthcare Team Outcomes
With the recent advances in transcatheter technologies, valve replacement techniques, and surgical repair, the community must establish institution-based standards to deliver high-quality cardiac care. Early diagnosis at the primary care level with providers, cardiologists, interventional cardiologists, and surgeons with timely referral to the higher center can improve outcomes. With optimal care and follow-up, serious side effects of severe aortic valve disease and HOCM, such as heart failure, bacterial endocarditis, and ventricular arrhythmias that lead to increased patient morbidity and mortality, can be prevented.
Interprofessional involvement by a team that includes clinicians (MDs, DOs, NPs, PAs), specialists (cardiologists, surgeons), and nursing staff in assessing and managing cardiac disease will lead to better outcomes. In cases where medication management is used, a cardiology specialty pharmacist may also be part of the care team. Each caregiver involved in the case must maintain open communication channels and accurate and updated records for the entire team. Nurses will often serve as coordinators for actions and communication between the various specists on the case, as well as providing patient counsel and assisting during surgical procedures. This interprofessional model will help drive the best patient results. [Level 5]
References
FLEMING PR. The mechanism of the pulsus bisferiens. British heart journal. 1957 Oct:19(4):519-24 [PubMed PMID: 13471818]
Chirinos JA, Akers SR, Vierendeels JA, Segers P. A Unified Mechanism for the Water Hammer Pulse and Pulsus Bisferiens in Severe Aortic Regurgitation: Insights from Wave Intensity Analysis. Artery research. 2018 Mar:21():9-12. doi: 10.1016/j.artres.2017.12.002. Epub 2017 Dec 21 [PubMed PMID: 29576810]
Broadbent W. Pulsus Bisferiens. British medical journal. 1899 Jan 14:1(1985):75-7 [PubMed PMID: 20758259]
Robertson WS,Tavel ME, Mid-systolic sound associated with aortic insufficiency and bisferiens pulse. Chest. 1983 Jan; [PubMed PMID: 6848320]
Level 3 (low-level) evidenceUmapathy S, Saxena A. Acute rheumatic fever presenting as complete heart block: report of an adolescent case and review of literature. BMJ case reports. 2018 Feb 11:2018():. pii: bcr-2017-223792. doi: 10.1136/bcr-2017-223792. Epub 2018 Feb 11 [PubMed PMID: 29440244]
Level 3 (low-level) evidenceGevers M, Van Genderingen HR, Van der Mooren K, Lafeber HN, Hack WW, Westerhof N. Bisferiens peaks in the radial artery pressure wave in newborn infants: a sign of patent ductus arteriosus. Pediatric research. 1995 Jun:37(6):800-5 [PubMed PMID: 7651767]
Level 2 (mid-level) evidenceAkinseye OA, Pathak A, Ibebuogu UN. Aortic Valve Regurgitation: A Comprehensive Review. Current problems in cardiology. 2018 Aug:43(8):315-334. doi: 10.1016/j.cpcardiol.2017.10.004. Epub 2017 Nov 2 [PubMed PMID: 29174586]
Maron BJ. Clinical Course and Management of Hypertrophic Cardiomyopathy. The New England journal of medicine. 2018 Aug 16:379(7):655-668. doi: 10.1056/NEJMra1710575. Epub [PubMed PMID: 30110588]
Husser D, Ueberham L, Jacob J, Heuer D, Riedel-Heller S, Walker J, Hindricks G, Bollmann A. Prevalence of clinically apparent hypertrophic cardiomyopathy in Germany-An analysis of over 5 million patients. PloS one. 2018:13(5):e0196612. doi: 10.1371/journal.pone.0196612. Epub 2018 May 3 [PubMed PMID: 29723226]
Barison A, Del Franco A, Todiere G. Haemodynamic findings in obstructive hypertrophic cardiomyopathy: pulsus bisferiens and Brockenbrough-Braunwald-Morrow sign. Journal of cardiovascular medicine (Hagerstown, Md.). 2016 Dec:17 Suppl 2():e154-e155. doi: 10.2459/JCM.0000000000000067. Epub [PubMed PMID: 28482353]
Maurer G. Aortic regurgitation. Heart (British Cardiac Society). 2006 Jul:92(7):994-1000 [PubMed PMID: 16775114]
Bekeredjian R, Grayburn PA. Valvular heart disease: aortic regurgitation. Circulation. 2005 Jul 5:112(1):125-34 [PubMed PMID: 15998697]
Shako D, Kawasaki T. Becker's sign and many other eponyms in aortic regurgitation. European heart journal. Case reports. 2021 Nov:5(11):ytab421. doi: 10.1093/ehjcr/ytab421. Epub 2021 Nov 4 [PubMed PMID: 34816085]
Level 3 (low-level) evidenceBons LR, Geenen LW, van den Hoven AT, Dik WA, van den Bosch AE, Duijnhouwer AL, Siebelink HJ, Budde RPJ, Boersma E, Wessels MW, van de Laar IMBH, DeRuiter MC, Goumans MJ, Loeys BL, Roos-Hesselink JW. Blood biomarkers in patients with bicuspid aortic valve disease. Journal of cardiology. 2020 Sep:76(3):287-294. doi: 10.1016/j.jjcc.2020.02.023. Epub 2020 Apr 4 [PubMed PMID: 32265086]
Lee JC, Branch KR, Hamilton-Craig C, Krieger EV. Evaluation of aortic regurgitation with cardiac magnetic resonance imaging: a systematic review. Heart (British Cardiac Society). 2018 Jan:104(2):103-110. doi: 10.1136/heartjnl-2016-310819. Epub 2017 Aug 19 [PubMed PMID: 28822982]
Level 1 (high-level) evidenceChoo WS, Steeds RP. Cardiac imaging in valvular heart disease. The British journal of radiology. 2011 Dec:84 Spec No 3(Spec Iss 3):S245-57. doi: 10.1259/bjr/54030257. Epub [PubMed PMID: 22723532]
Sherrid MV,Shetty A,Winson G,Kim B,Musat D,Alviar CL,Homel P,Balaram SK,Swistel DG, Treatment of obstructive hypertrophic cardiomyopathy symptoms and gradient resistant to first-line therapy with β-blockade or verapamil. Circulation. Heart failure. 2013 Jul; [PubMed PMID: 23704138]
Sankar MN, Bhombal S, Benitz WE. PDA: To treat or not to treat. Congenital heart disease. 2019 Jan:14(1):46-51. doi: 10.1111/chd.12708. Epub [PubMed PMID: 30811796]
Medical Masterclass contributors, Firth J. Cardiology: hypertrophic cardiomyopathy. Clinical medicine (London, England). 2019 Jan:19(1):61-63. doi: 10.7861/clinmedicine.19-1-61. Epub [PubMed PMID: 30651247]
Nemri AM. Patent ductus arteriosus in preterm infant: Basic pathology and when to treat. Sudanese journal of paediatrics. 2014:14(1):25-30 [PubMed PMID: 27493386]
Moriya S,Iga K,Konishi T, Dicrotic pulse observed in a patient with prolapse of the aortic valve without aortic regurgitation. Heart and vessels. 1997; [PubMed PMID: 9846812]
Level 3 (low-level) evidenceHardarson T, De la Calzada CS, Curiel R, Goodwin JF. Prognosis and mortality of hypertrophic obstructive cardiomyopathy. Lancet (London, England). 1973 Dec 29:2(7844):1462-7 [PubMed PMID: 4129311]
Norrish G, Jager J, Field E, Quinn E, Fell H, Lord E, Cicerchia MN, Ochoa JP, Cervi E, Elliott PM, Kaski JP. Yield of Clinical Screening for Hypertrophic Cardiomyopathy in Child First-Degree Relatives. Circulation. 2019 Jul 16:140(3):184-192. doi: 10.1161/CIRCULATIONAHA.118.038846. Epub 2019 Apr 22 [PubMed PMID: 31006259]